Skip navigation
walgreens_names_tim_wentworth_as_new_ceo_720.png Getty Images
Wentworth replaces Roz Brewer, who left the Northbrook, Ill.-based company in September.

Walgreens names Tim Wentworth as new CEO

Wentworth steps in during turbulent times that includes a pharmacist walkout, vacant c-suite positions

Tim Wentworth is now the new CEO of Walgreens Boots Alliance, reports the Wall Street Journal.

Wentworth replaces Roz Brewer, who left the Northbrook, Ill.-based company in September. Ginger Graham,the lead independent director for Walgreens Boots Alliance’s Board of Directors, was serving as the interim CEO.

Wentworth, who will start at Walgreens on Oct. 23, comes with a noteworthy pharmaceutical background, as he was the CEO of one of the biggest pharmacy benefit managers in the country — Express Scripts which is now part of Cigna Group. Before taking the head job at Walgreens he was leading Cigna’s Evernorth health services arm.

It is not the ideal time to be in charge of Walgreens. Earlier this week groups of pharmacists walked off the job protesting heavy workloads and the company is facing financial hardships.

Walgreens will release quarterly earnings on Thursday and analysts say it could be a rocky one.

Brewer described the company’s third quarter performance as “disappointing,” as net earnings were down significantly compared to the third quarter of 2022 ($118 million vs. $289 million).

High-ranking positions need to be filled. Chief Information Officer Hsiao Wang stepped down in early October and James Kehoe, Walgreens’ chief financial officer, left in July after five years with the company.

Lawsuits have also been a burden. Walgreens is being accused of a grossly inflated fee bid in a health plans lawsuit that involves Blue Cross and Blue Shield of Minnesota.

The pharmacy has been served with a proposed class action in a Florida federal court over claims it mislabeled eye drops for treating pink eye and misled consumers into believing the product was safe and effective.

Then there are the opioid settlements, including one worth $285 million in Nevada.

Walgreens has also laid off over 500 workers since the beginning of the year.

Wentworth, however, knows what he is getting into, as he met with each individual Walgreens Boots Alliance board member and is “very comfortable that the board…is going to be supportive of my success and that of the company,” he told the Wall Street Journal.

Executive Chairman of Walgreens Boots Alliance Stefano Pessina will work closely with Wentworth, and he said the company hired the right professional for the job.

“We are confident he is the right person to lead WBA’s next phase of growth into a customer-centric healthcare company,” said Pessina. “I look forward to working with Tim, as well as the rest of the board and WBA leadership, to lead WBA into a successful future.

 

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish